Uninterrupted direct oral anticoagulants and vitamin K antagonists during ablation for atrial fibrillation: an updated meta-analysis

MLA

Yvonne Heinen, et al. “Uninterrupted Direct Oral Anticoagulants and Vitamin K Antagonists during Ablation for Atrial Fibrillation: An Updated Meta-Analysis.” European Heart Journal, vol. 41, Nov. 2020. EBSCOhost, https://doi.org/10.1093/ehjci/ehaa946.0569.

APA

Yvonne Heinen, Maximilian Brockmeyer, C Parco, Hisaki Makimoto, P Mueller, Georg Wolff, T Krieger, Athanasios Karathanos, Yingfeng Lin, Volker Schulze, Malte Kelm, & Alexandru Bejinariu. (2020). Uninterrupted direct oral anticoagulants and vitamin K antagonists during ablation for atrial fibrillation: an updated meta-analysis. European Heart Journal, 41. https://doi.org/10.1093/ehjci/ehaa946.0569

Chicago

Yvonne Heinen, Maximilian Brockmeyer, C Parco, Hisaki Makimoto, P Mueller, Georg Wolff, T Krieger, et al. 2020. “Uninterrupted Direct Oral Anticoagulants and Vitamin K Antagonists during Ablation for Atrial Fibrillation: An Updated Meta-Analysis.” European Heart Journal 41 (November). doi:10.1093/ehjci/ehaa946.0569.